The periodontal gel industry in the United States is on track for substantial expansion, driven by increasing consumer awareness and a heightened focus on preventive dental care. Recent market projections indicate a robust Compound Annual Growth Rate (CAGR) of 3.1% through 2034, with sales expected to grow from USD 179.9 million in 2024 to USD 241.4 million by 2034.
The surge in market growth is primarily attributed to the rising awareness of oral health and the growing emphasis on preventive measures. As consumers become more educated about the link between oral health and overall well-being, there is a marked increase in the demand for advanced periodontal solutions. This trend is fueling the development and adoption of innovative periodontal gels designed to improve oral health and prevent periodontal diseases.
Unlock The Door To Innovation And Prosperity By Our Exclusive Sample Report
Despite its promising trajectory, the periodontal gel industry faces notable challenges. A significant hurdle stems from the stringent regulatory landscape governing oral care products. The approval process for new formulations is rigorous, often resulting in delays in market entry. Additionally, economic factors such as the impact of global financial fluctuations can act as restraints, influencing consumer spending on non-essential healthcare products.
As the industry navigates these challenges, stakeholders are proactively innovating to meet the evolving needs of consumers. Advanced research and development efforts are underway to introduce novel formulations that comply with regulatory standards while addressing consumer preferences for effective oral care solutions.
Key Takeaways from the Market Study:
- By active ingredients, the anti-microbial agents are expected to hold over 7% market value share by 2023 and are expected to display a CAGR of 1.8% over the forecast period owing to their targeted action against bacteria, localized application, minimally invasive nature, reduced side effects, and the evidence supporting their efficacy.
- By application, the gingivitis segment holds a lucrative market share of 5 % with a CAGR of 1.7% as the rising prevalence of gingivitis due to lifestyle change.
- By distribution channel, retail sales hold a leading segment share in terms of the market share value of 5% in 2023. Due to the over-the-counter availability of the gels and the ease of accessibility, the demand for retail sales is dominating the market.
- Northeast is considered the leading region with a value share of 6% at the end of the forecast period, owing to its well-established healthcare infrastructure, including hospitals, specialized clinics, and healthcare facilities that offer comprehensive dialysis services.
“The periodontal gel market in the United States has undergone significant transformations throughout its history, shaped by changing healthcare practices, technological advancements, and shifting consumer preferences,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Competitive Landscape:
The periodontal gel industry in the United States is a dynamic and competitive space characterized by a diverse array of players vying for market share. These entities can be broadly classified into three primary groups. Established pharmaceutical companies, exemplified by industry giants like Colgate-Palmolive and Johnson & Johnson, wield extensive resources, brand recognition, and well-established distribution networks. Their focus often centers on developing innovative periodontal gel formulations and expanding product lines to address specific patient needs.
Generic drug manufacturers, such as Teva Pharmaceutical Industries and Mylan N.V., specialize in offering more affordable alternatives, leveraging their manufacturing expertise and cost-efficiency to secure market share. Emerging startups, including Parodontax and AperioGen, bring fresh perspectives and innovative approaches to periodontal gel development, concentrating on unique formulations, targeted delivery mechanisms, and personalized treatment plans.
- DENTAID introduces PerioAid bioadhesive gel, which has antiseptic, regenerative, and healing properties due to its proprietary formulation, which incorporates the innovative DENTAID technology hyaluronrepair.
Get Full Report Access Elevate Your Business Strategy
Key Companies Profiled:
- Ivoclar Vivadent
- Straumann
- 3M
- Dentaid
- Dentovations Inc. (Oxyfresh)
- DENTSPLY SIRONA
- Himalaya Wellness
- Sunstar Group
- Septodont
- Henry Schein
- Perio Protect
- Den-Mat Holdings, LLC
- FREZYDERM S.A
- Curaden AG
Key Segments Covered in Periodontal Gel Industry Research:
By Active Ingredients:
- Anti-microbial Agents
- Antibiotics
- Anti-inflammatory Agents
- Antiseptics
- Others
By Application:
- Periodontitis
- Gingivitis
- Oral Ulcers and Lesions
- Orthodontics
- Other
By Distribution Channel:
- Institutional Sales
- Dental Hospitals
- Dental Clinics
- Group Dental Practices
- Retail Sales
- Retail Pharmacies
- Drug Stores
- Hypermarkets and Supermarkets
- Online Sales
By Region:
- Northeast
- Midwest
- Southeast
- Southwest
- West
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube